title: Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart.
abstract: Endogenous B-type natriuretic peptide (BNP) is thought to be produced in the cardiac ventricles. After sub-total cardiectomy and implantation of a total artificial heart (TAH), the abrupt withdrawal of BNP impairs renal function despite normal hemodynamic variables. We hypothesized that abrupt withdrawal of endogenous BNP may impair renal function and volume homeostasis and BNP may have a direct renal influence unrelated to its cardiovascular effect. Nesiritide infusion should be supplemented in the interim and weaned slowly until BNP levels normalize, which suggests that BNP is produced in tissues other than the cardiac ventricles.
authors.affiliation: Department of Cardiology, Texas Heart Institute, Houston, 77225, USA.
authors.forename: Reynolds
authors.initials: R
authors.lastname: Delgado
authors.forename: Yasmin
authors.initials: Y
authors.lastname: Wadia
authors.forename: Biswajit
authors.initials: B
authors.lastname: Kar
authors.forename: Whitson
authors.initials: W
authors.lastname: Ethridge
authors.forename: Aly
authors.initials: A
authors.lastname: Zewail
authors.forename: Toni
authors.initials: T
authors.lastname: Pool
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Myers
authors.forename: Nancy
authors.initials: N
authors.lastname: Scroggins
authors.forename: O H
authors.initials: OH
authors.lastname: Frazier
mesh_terms: D058186:Acute Kidney Injury / Q000175:diagnosis / Q000188:drug therapy*; D000368:Aged; D015415:Biomarkers / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006333:Heart Failure / Q000175:diagnosis / Q000601:surgery*; D006354:Heart, Artificial / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000008:administration & dosage*; D045265:Natriuretic Peptides / Q000032:analysis / Q000378:metabolism*; D018570:Risk Assessment; D012494:Sampling Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D045265:Natriuretic Peptides; D020097:Natriuretic Peptide, Brain